To access the live webcast of the fireside chat, please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a ...

Analysts at HC Wainwright cut their FY2024 earnings estimates for shares of Mawson Infrastructure Group in a note issued to investors on Tuesday, November 26th. HC Wainwright analyst K. Dede now ...

Alector, Inc. (NASDAQ:ALEC – Free Report) – HC Wainwright issued their Q1 2025 EPS estimates for shares of Alector in a ...

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of SoundHound AI ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Fintel reports that on November 26, 2024, HC Wainwright & Co. downgraded their outlook for Poseida Therapeutics ...

Fintel reports that on November 25, 2024, HC Wainwright & Co. downgraded their outlook for Mainz Biomed N.V. (NasdaqCM:MYNZ) ...

We recently published a list of 10 Best Silver Mining Stocks to Buy Right Now. In this article, we are going to take a look at where MAG Silver Corp.

Analysts at HC Wainwright upped their price target on the shares of MAG Silver Corp. (NYSE:MAG) from $17.00 to $18.00, giving ...

H.C. Wainwright analyst Joseph Pantginis says Leerink this morning downgraded Compass Therapeutics (CMPX) saying the company’s biliary tract cancer opportunity is priced into the shares.

HC, which downgraded Ardelyx to Neutral from ... uncertainty around Medicare patient access for XPHOZAH,” noted H.C. Wainwright analyst Ed Arce. Citi also reduced its price target for the ...